tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Cash flow

Compare
532 Followers

Supernus Pharmaceuticals Cash Flow

SUPN's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, SUPN's free cash flow was decreased by $60.69M and operating cash flow was $0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 171.95M$ 111.08M$ 116.83M$ 127.13M$ 138.40M
Investing Cash Flow
$ -189.87M$ 268.73M$ -216.66M$ -81.91M$ -34.70M
Financing Cash Flow
$ 12.19M$ -397.88M$ -10.48M$ -130.42M$ 3.56M
End Cash Position
$ 69.33M$ 75.05M$ 93.12M$ 203.43M$ 288.64M
Free Cash Flow
$ 171.23M$ 110.53M$ 116.41M$ 125.08M$ 134.95M
Currency in USD

Supernus Pharmaceuticals Cash Flow